메뉴 건너뛰기




Volumn 2, Issue 1, 2010, Pages

Recent advances in preventing cardiovascular disorders by managing lipid levels

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ATORVASTATIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; EPROTIROME; EZETIMIBE; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LAROPIPRANT; LAROPIPRANT PLUS NICOTINIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; NICOTINIC ACID DERIVATIVE; OMEGA 3 FATTY ACID; PLACEBO; ROSUVASTATIN; SIMVASTATIN; TREDAPTIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

EID: 78649384743     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M2-66     Document Type: Short Survey
Times cited : (1)

References (15)
  • 1
  • 4
    • 34447550510 scopus 로고    scopus 로고
    • Poor prognosis of heart transplant patients with end-stage renal failure
    • DOI 10.1093/ndt/gfl811
    • Kjekshus J, Apetrei E, Barrios V, Böhm M, Cleland JG, Cornel JH, Dunselman P, Fonseca C, Goudev A, Grande P, Gullestad L, Hjalmarson A, Hradec J, Jánosi A, Kamenský G, Komajda M, Korewicki J, Kuusi T, Mach F, Mareev V, McMurray JJ, Ranjith N, Schaufelberger M, Vanhaecke J, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Group: Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007, 357:2248-61. (Pubitemid 47072227)
    • (2007) Nephrology Dialysis Transplantation , vol.22 , Issue.5 , pp. 1383-1389
    • Villar, E.1    Boissonnat, P.2    Sebbag, L.3    Hendawy, A.4    Cahen, R.5    Trolliet, P.6    Labeeuw, M.7    Ecochard, R.8    Pouteil-Noble, C.9
  • 5
    • 53049095795 scopus 로고    scopus 로고
    • Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebo-controlled trial
    • Gissi-HF Investigators
    • Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1231-9.
    • (2008) Lancet , vol.372 , pp. 1231-1239
    • Tavazzi, L.1    Maggioni, A.P.2    Marchioli, R.3    Barlera, S.4    Franzosi, M.G.5    Latini, R.6    Lucci, D.7    Nicolosi, G.L.8    Porcu, M.9    Tognoni, G.10
  • 6
    • 70350512957 scopus 로고    scopus 로고
    • Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: Prediction of cardiovascular events and interaction with the effects of rosuvastatin: A report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure)
    • CORONA Study Group
    • Cleland JG, McMurray JJ, Kjekshus J, Cornel JH, Dunselman P, Fonseca C, Hjalmarson A, Korewicki J, Lindberg M, Ranjith N, van Veldhuisen DJ, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group: Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure). J Am Coll Cardiol 2009, 54:1850-9.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 1850-1859
    • Cleland, J.G.1    McMurray, J.J.2    Kjekshus, J.3    Cornel, J.H.4    Dunselman, P.5    Fonseca, C.6    Hjalmarson, A.7    Korewicki, J.8    Lindberg, M.9    Ranjith, N.10    Van Veldhuisen, D.J.11    Waagstein, F.12    Wedel, H.13    Wikstrand, J.14
  • 9
    • 22344458137 scopus 로고    scopus 로고
    • Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
    • Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E; German Diabetes and Dialysis Study Investigators: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005, 353:238-48.
    • (2005) N Engl J Med , vol.353 , pp. 238-248
    • Wanner, C.1    Krane, V.2    März, W.3    Olschewski, M.4    Mann, J.F.5    Ruf, G.6    Ritz, E.7
  • 11
    • 68049114763 scopus 로고    scopus 로고
    • Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in Endpoints through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease
    • Steering Committees of IDEAL and TNT Trials
    • Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters DD, Pedersen TR; Steering Committees of IDEAL and TNT Trials: Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in Endpoints through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease. Am J Cardiol 2009, 104:459-63.
    • (2009) Am J Cardiol , vol.104 , pp. 459-463
    • Faergeman, O.1    Holme, I.2    Fayyad, R.3    Bhatia, S.4    Grundy, S.M.5    Kastelein, J.J.6    LaRosa, J.C.7    Larsen, M.L.8    Lindahl, C.9    Olsson, A.G.10    Tikkanen, M.J.11    Waters, D.D.12    Pedersen, T.R.13
  • 13
    • 50949102416 scopus 로고    scopus 로고
    • Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes
    • IMPROVE-IT Investigators
    • Cannon CP, Giugliano RP, Blazing MA, Harrington RA, Peterson JL, Sisk CM, Strony J, Musliner TA, McCabe CH, Veltri E, Braunwald E, Califf RM; IMPROVE-IT Investigators: Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes. Am Heart J 2008, 156:826-32.
    • (2008) Am Heart J , vol.156 , pp. 826-832
    • Cannon, C.P.1    Giugliano, R.P.2    Blazing, M.A.3    Harrington, R.A.4    Peterson, J.L.5    Sisk, C.M.6    Strony, J.7    Musliner, T.A.8    McCabe, C.H.9    Veltri, E.10    Braunwald, E.11    Califf, R.M.12


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.